3 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow this condition Literature Review of Urinary Tract Infection (UTI) trials Research Report on Urinary Tract Infection (UTI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Automatic Versus As-Needed Follow-up After Hospitalization for Children With Medical Complexity Automatic follow-up recommendation, As-needed follow-up recommendation - Children With Medical Complexity, Respiratory Tract Infections (RTI) | Not applicable | Not yet recruiting | Seattle Children's Hospital | 160 | 2026-10-01 | 2026-10-08 |
| Alternative Prophylaxis in Female Recurrent Urinary Tract Infections intravesical instillation with HA-CS, intravesical instillation of sterile purified water - Urinary Tract Infections, Urinary Tract Infection (UTI) | Phase 4 | Recruiting | University Hospital, Basel, Switzerland | 50 | 2020-10-27 | 2025-02-19 |
| The INSPIRE-ASP UTI Trial Routine Care, INSPIRE CPOE Smart Prompt - Urinary Tract Infection (UTI) | Not applicable | Completed | Harvard Pilgrim Health Care | 55412 | 2018-10-01 | 2025-01-30 |
| Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g) - Urinary Tract Infection (UTI), Complicated Urinary Tract Infection | Phase 3 | Completed | Merck Sharp & Dohme LLC | 115 | 2016-04-14 | 2019-02-05 |
| Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2 Nitrofurantoin 100 MG, 7d, Gentamicin, 5mg/kg, Ampicillin 2g - Nephrolithiasis, Urinary Tract Infection (UTI) | Not applicable | Completed | University of California, San Diego | 330 | 2016-01-01 | 2025-03-06 |
| Urell and Pregnancy URELL, Placebo - Urinary Tract Infection (UTI) | Not applicable | Terminated | Hopital Foch | 11 | 2010-05-01 | 2013-03-26 |
Urinary Tract Infections (6) · Nephrolithiasis (1) · Pyelonephritis (1) · Respiratory Tract Infections (1) · Sepsis (1) · Soft Tissue Infections (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Infections (6) · Male Urogenital Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Kidney Diseases (2) · Inflammation (1) · Nephritis (1) · Nephritis, Interstitial (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pyelitis (1) · Respiratory Tract Diseases (1) · Systemic Inflammatory Response Syndrome (1)
Administration, Intravesical (1) · Ampicillin (1) · Gentamicins (1) · Nitrofurantoin (1) · Tazobactam (1) · ceftolozane (1)
Harvard Pilgrim Health Care (1) · Hopital Foch (1) · Merck Sharp & Dohme LLC (1) · Seattle Children's Hospital (1) · University Hospital, Basel, Switzerland (1) · University of California, San Diego (1)
United States (3) · France (1) · Switzerland (1)
Kathrin Bausch, Dr. med (1) · Nassr Nama, MD, MSc (1) · Richard Platt, MD, MS (1) · Shruti Gohil, MD, MPH (1) · Susan Huang, MD, MPH (1)
PMID 18280509, PMID 20570319, PMID 21247286, PMID 21567157, PMID 21944106, PMID 33369488, PMID 38639723, PMID 42268612
2019 (1)